Literature DB >> 11875005

Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.

Olivier Morteau1, Ignazio Castagliuolo, Andreas Mykoniatis, Jeff Zacks, Michael Wlk, Bao Lu, Charalabos Pothoulakis, Norma P Gerard, Craig Gerard.   

Abstract

BACKGROUND & AIMS: The role of the CC chemokine receptor (CCR) 1 in acute enteritis was investigated by subjecting CCR1 knockout mice to Clostridium difficile toxin A treatment.
METHODS: Toxin A or vehicle was injected into ileal loops in anesthetized wild-type, CCR1-/- and macrophage inhibitory protein (MIP)-1alpha-/- mice. After 1-4 hours, fluid accumulation was calculated, and the loops were processed for histology, myeloperoxidase activity, regulated on activation, normal T cell expressed and secreted (RANTES) production, and messenger RNA measurements.
RESULTS: Toxin A induced in all mice a significant (P < 0.05) increase in ileal fluid accumulation, epithelial damage, and neutrophil infiltration, with all parameters being significantly (P < 0.01) lower in CCR1-/- and MIP-1alpha-/- mice. Ileal messenger RNA expression of the CCR1 ligands MIP-1alpha and RANTES and RANTES synthesis were increased in toxin A-treated wild-type mice. The RANTES antagonist Met-RANTES significantly (P < 0.01) reduced the toxin A-induced increases in ileal fluid accumulation and myeloperoxidase activity in wild-type mice.
CONCLUSIONS: C. difficile toxin A-induced murine enteritis involves CCR1 and its ligands MIP-1alpha and RANTES, which may be important mediators of the neutrophil recruitment characterizing acute, enterotoxin-mediated enteritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875005     DOI: 10.1053/gast.2002.31873

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Genes differentially regulated by NKX2-3 in B cells between ulcerative colitis and Crohn's disease patients and possible involvement of EGR1.

Authors:  Wei Yu; Zhenwu Lin; John P Hegarty; Xi Chen; Ashley A Kelly; Yunhua Wang; Lisa S Poritz; Walter A Koltun
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Protease-activated receptor 2, dipeptidyl peptidase I, and proteases mediate Clostridium difficile toxin A enteritis.

Authors:  Graeme S Cottrell; Silvia Amadesi; Stella Pikios; Eric Camerer; J Adam Willardsen; Brett R Murphy; George H Caughey; Paul J Wolters; Shaun R Coughlin; Anders Peterson; Wolfgang Knecht; Charalabos Pothoulakis; Nigel W Bunnett; Eileen F Grady
Journal:  Gastroenterology       Date:  2007-04-13       Impact factor: 22.682

4.  Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo.

Authors:  Cynthia A Bonville; Vincent K Lau; Jordana M DeLeon; Ji-Liang Gao; Andrew J Easton; Helene F Rosenberg; Joseph B Domachowske
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation.

Authors:  Kara L Conway; Gautam Goel; Harry Sokol; Monika Manocha; Emiko Mizoguchi; Cox Terhorst; Atul K Bhan; Agnès Gardet; Ramnik J Xavier
Journal:  J Immunol       Date:  2012-08-22       Impact factor: 5.422

6.  In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.

Authors:  Kevin M D'Auria; Glynis L Kolling; Gina M Donato; Cirle A Warren; Mary C Gray; Erik L Hewlett; Jason A Papin
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

7.  Acute infection of mice with Clostridium difficile leads to eIF2α phosphorylation and pro-survival signalling as part of the mucosal inflammatory response.

Authors:  Amir A Sadighi Akha; Casey M Theriot; John R Erb-Downward; Andrew J McDermott; Nicole R Falkowski; Heather M Tyra; D Thomas Rutkowski; Vincent B Young; Gary B Huffnagle
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

Review 8.  Immune responses to Clostridium difficile infection.

Authors:  Rajat Madan; William A Petri
Journal:  Trends Mol Med       Date:  2012-10-16       Impact factor: 11.951

Review 9.  Host recognition of Clostridium difficile and the innate immune response.

Authors:  Carrie A Cowardin; William A Petri
Journal:  Anaerobe       Date:  2014-09-16       Impact factor: 3.331

10.  Tumor microenvironment immune-related lncRNA signature for patients with melanoma.

Authors:  Jia-Hui Guo; Shan-Shan Yin; Hua Liu; Feng Liu; Feng-Hou Gao
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.